Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.29 USD | -3.79% | -4.59% | +15.65% |
Evolution of the average Target Price on ProQR Therapeutics N.V.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering ProQR Therapeutics N.V.
Chardan Research | |
Raymond James | |
Citigroup | |
Cantor Fitzgerald | |
HC Wainwright | |
JMP Securities | |
Stifel Nicolaus | |
Chardan |
EPS Revisions
- Stock
- Equities
- Stock ProQR Therapeutics N.V. - Nasdaq
- Consensus ProQR Therapeutics N.V.